S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
LAB · Standard BioTools Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Standard BioTools Inc (LAB)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$0.64
-0.00
(-0.28%)
● At close: October 21 at 4:00:00 PM EDT
$0.65
+0.00
(+0.00%)
After-Hours:
4:02:01 PM EDT
DAY'S RANGE
$0.64
$0.64
$0.66
52-WEEK RANGE
$0.64
$0.62
$1.72
What's happening
- LAB is down 0.28% today, trading at $0.64. — Live quote
- It's trading within 3% of its 52-week low ($0.62). (Finnhub fundamentals)
- Volume today (18,331) is well below its 3-month average of 2,219,880. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.03 actual vs. $-0.01 estimated (-129.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 4
Strong sell 1
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
LAB
-50.21%
vs S&P 500
-62.99%
1-YEAR RETURN
LAB
-50.21%
vs S&P 500
-64.77%
6-MONTH RETURN
LAB
-30.73%
3-MONTH RETURN
LAB
-27.92%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.03
Est. $-0.01
MISS -129.0%
2026-04-26 (Q1 2026)
$0.33
Est. $-0.05
BEAT +800.6%
2026-01-26 (Q4 2025)
$0.05
Est. $-0.07
BEAT +170.7%
2025-10-26 (Q3 2025)
$-0.09
Est. $-0.06
MISS -61.9%
Valuation Measures & Ratios
Enterprise Value4-$19.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)2.96
Price / Book70.60
EV4 / Revenue-0.23
EV4 / EBITDA—
Profit Margin100.37%
Operating Margin-112.85%
Return on Equity (ROE8)17.64%
Return on Assets (ROA9)14.31%
Avg Volume (3M)2,219,880
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $314.6M | $353.9M | $501.0M | $444.3M | $401.7M |
| P/E | 9.78 | 10.76 | -4.14 | -3.36 | -3.07 |
| Price/Sales | 3.81 | 4.28 | 5.99 | 5.13 | 3.64 |
| Price/Book | 0.58 | 0.63 | 1.25 | 1.05 | 0.88 |
| EV/Revenue | 0.54 | 1.07 | 4.44 | 3.30 | 2.27 |
| EV/EBITDA | -0.50 | -0.99 | -3.67 | — | — |
| ROE | 5.96% | 5.86% | -30.31% | -31.13% | -28.78% |
| ROA | 5.13% | 5.15% | -22.44% | -23.73% | -22.58% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,520,686
Change from Prior Settlement-2.80%
% of Float—
Days to Cover (Short Ratio)2.72
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Net profit margin is 100.4%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -7.6% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is -50.2%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on LAB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1M | $21.1M | $19.6M | $21.8M | $20.2M | $22.1M | $22.5M | $45.5M |
| Gross profit | $10.5M | $11.3M | $9.5M | $10.6M | $11.0M | $12.1M | $10.4M | $24.2M |
| Operating income | -$25.4M | -$12.5M | -$32.9M | -$25.7M | -$27.0M | -$26.7M | -$30.3M | -$60.2M |
| Net income | -$26.8M | $127.1M | -$34.7M | -$33.5M | -$26.0M | -$26.9M | -$45.7M | -$32.2M |
| EPS (diluted) | $-0.07 | $0.33 | $-0.09 | $-0.09 | $-0.07 | $-0.07 | $-0.12 | $-0.27 |
| EPS (basic) | $-0.07 | $0.33 | $-0.09 | $-0.09 | $-0.07 | $-0.07 | $-0.12 | $-0.27 |
| Operating margin | -$126 | -$59 | -$168 | -$118 | -$133 | -$121 | -$135 | -$132 |
| Net margin | -$133 | $601 | -$177 | -$154 | -$129 | -$122 | -$203 | -$71 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $627.2M | $639.1M | $567.8M | $539.6M | $557.0M | $579.6M | $612.3M | $681.5M |
| Total liabilities | $87.2M | $78.0M | $143.5M | $140.0M | $132.4M | $125.0M | $140.6M | $192.2M |
| Stockholders' equity | $540.0M | $561.1M | $424.3M | $399.7M | $424.5M | $454.6M | $471.7M | $489.3M |
| Total current assets | $516.9M | $521.5M | $454.3M | $472.4M | $506.0M | $344.0M | $375.9M | $453.6M |
| Total current liabilities | $56.8M | $42.2M | $108.3M | $108.0M | $98.0M | $56.2M | $65.9M | $120.6M |
| Cash & equivalents | $270.0M | $265.8M | $120.9M | $129.4M | $158.6M | $150.9M | $166.7M | $210.6M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $15.7M | $16.6M | $13.4M | $13.5M | $14.6M | $35.5M | $14.7M | $35.3M |
| Inventory | $17.1M | $18.6M | $20.0M | $25.4M | $24.2M | $42.1M | $20.7M | $42.6M |
| Marketable securities (non-current) | $67.3M | $71.4M | $25.7M | $19.5M | — | — | $0 | — |
| Property, plant & equipment | $15.3M | $17.1M | $19.3M | $20.7M | $22.7M | $43.6M | $22.8M | $42.0M |
| Goodwill | — | — | — | — | — | $111.7M | $111.3M | $106.3M |
| Intangible assets | — | — | — | — | — | $28.1M | $29.0M | $23.4M |
| Other non-current assets | $3.3M | $3.4M | $3.2M | $3.5M | $3.7M | $6.5M | $3.5M | $4.6M |
| Accounts payable | $9.6M | $8.0M | $5.4M | $6.6M | $7.3M | $11.8M | $5.0M | $10.9M |
| Accrued liabilities | $29.6M | $15.7M | $29.8M | $30.8M | $24.2M | $22.0M | $21.4M | $31.7M |
| Deferred revenue (current) | $9.1M | $10.0M | $38.9M | $40.1M | $40.2M | $12.8M | $10.3M | $13.4M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | $299.0K | $55.2M |
| Other non-current liabilities | $1.1M | $4.4M | $1.2M | $1.2M | $1.2M | $3.5M | $1.1M | $1.5M |
| Common stock & paid-in capital | $410.0K | $408.0K | $404.0K | $401.0K | $400.0K | $397.0K | $396.0K | $390.0K |
| Retained earnings | -$1.16B | -$1.13B | -$1.26B | -$1.28B | -$1.25B | -$1.21B | -$1.19B | -$1.15B |
| Accumulated other comprehensive income (loss) | $1.2M | -$511.0K | -$1.5M | -$477.0K | -$1.9M | $1.2M | $1.2M | -$1.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$10.3M | -$46.6M | -$1.2M | -$22.2M | -$20.7M | -$30.3M | -$14.1M | -$27.9M |
| Investing cash flow | $14.4M | $191.1M | -$8.0M | -$6.7M | $27.5M | $14.6M | $25.7M | -$30.9M |
| Financing cash flow | -$138.0K | -$40.0K | $620.0K | -$112.0K | $108.0K | -$46.0K | -$54.5M | -$2.0K |
| Free cash flow | -$10.7M | -$47.2M | -$1.7M | -$23.1M | -$22.6M | -$35.3M | -$17.4M | -$30.1M |
| Capital expenditures | $344.0K | $570.0K | $476.0K | $886.0K | $1.9M | $5.1M | $3.4M | $2.3M |
| Depreciation & amortization | $1.3M | $1.4M | $1.3M | $1.5M | $3.2M | $3.3M | $3.1M | $3.1M |
| Share-based compensation | $4.0M | $8.8M | $5.7M | $8.5M | $6.4M | $9.0M | $7.5M | $5.9M |
| Deferred income taxes | — | — | -$38.8M | — | — | — | $206.0K | — |
| Change in accounts receivable | -$1.2M | $1.9M | -$6.7M | $5.8M | $276.0K | $2.0M | -$6.7M | $2.7M |
| Change in inventory | -$1.2M | -$1.9M | $1.2M | $1.8M | $4.7M | $3.8M | -$5.0M | $2.1M |
| Change in accounts payable | $1.7M | -$1.2M | $653.0K | $946.0K | $1.4M | -$578.0K | -$88.0K | -$2.2M |
| Purchases of investments | $2.0K | $837.0K | $6.9M | — | $0 | $0 | $0 | — |
| Share repurchases | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $258.0K | $118.0K | $126.0K | $112.0K | $200.0K | $46.0K | $45.0K | $70.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $85.3M | $91.0M | $106.3M | $97.9M | $130.6M |
| Gross profit | $42.5M | $44.9M | $50.5M | $37.1M | — |
| Operating income | -$110.2M | -$127.5M | -$76.6M | -$116.2M | -$67.5M |
| Net income | -$74.9M | -$138.9M | -$74.7M | -$190.1M | -$59.2M |
| EPS (diluted) | $-0.20 | $-0.52 | $-0.94 | $-2.43 | $-0.78 |
| EPS (basic) | $-0.20 | $-0.52 | $-0.94 | $-2.43 | $-0.78 |
| Operating margin | -$129 | -$140 | -$72 | -$119 | -$52 |
| Net margin | -$88 | -$153 | -$70 | -$194 | -$45 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $567.8M | $612.3M | $323.1M | $390.3M | $275.2M |
| Total liabilities | $143.5M | $140.6M | $159.9M | $160.5M | $180.6M |
| Stockholders' equity | $424.3M | $471.7M | -$148.1M | -$81.5M | $94.6M |
| Total current assets | $454.3M | $375.9M | $158.2M | $208.8M | $72.1M |
| Total current liabilities | $108.3M | $65.9M | $109.3M | $43.4M | $49.6M |
| Cash & equivalents | $120.9M | $166.7M | $51.7M | $81.3M | $28.5M |
| Marketable securities (current) | — | — | — | $84.5M | — |
| Accounts receivable | $13.4M | $14.7M | $19.7M | $17.3M | $18.3M |
| Inventory | $20.0M | $20.7M | $20.5M | $21.5M | $20.8M |
| Marketable securities (non-current) | $25.7M | $0 | — | — | — |
| Property, plant & equipment | $19.3M | $22.8M | $24.2M | $25.7M | $28.0M |
| Goodwill | — | $111.3M | $106.3M | $106.3M | $106.4M |
| Intangible assets | — | $29.0M | $1.4M | $12.6M | $27.9M |
| Other non-current assets | $3.2M | $3.5M | $2.3M | $3.1M | $3.7M |
| Accounts payable | $5.4M | $5.0M | $9.2M | $7.9M | $10.6M |
| Accrued liabilities | $29.8M | $21.4M | $21.0M | $6.2M | $8.7M |
| Deferred revenue (current) | $38.9M | $10.3M | $11.6M | $10.8M | $11.9M |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | $299.0K | $63.5M | $64.9M | — |
| Other non-current liabilities | $1.2M | $1.1M | $1.1M | $961.0K | $882.0K |
| Common stock & paid-in capital | $404.0K | $396.0K | $83.0K | $80.0K | $77.0K |
| Retained earnings | -$1.26B | -$1.19B | -$1.00B | -$926.1M | -$736.0M |
| Accumulated other comprehensive income (loss) | -$1.5M | $1.2M | -$2.2M | -$1.9M | -$907.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$74.3M | -$143.5M | -$43.3M | -$89.4M | -$44.1M |
| Investing cash flow | $27.4M | $363.2M | $20.2M | -$88.1M | -$11.9M |
| Financing cash flow | $570.0K | -$102.6M | -$6.8M | $230.8M | $16.0M |
| Free cash flow | -$82.6M | -$151.8M | -$46.1M | -$93.2M | -$57.3M |
| Capital expenditures | $8.3M | $8.4M | $2.8M | $3.8M | $13.3M |
| Depreciation & amortization | $9.3M | $12.5M | $4.0M | $3.5M | $3.7M |
| Share-based compensation | $29.6M | $31.7M | $13.1M | $14.9M | $16.1M |
| Deferred income taxes | -$38.8M | $206.0K | -$118.0K | -$3.3M | -$4.3M |
| Change in accounts receivable | $1.4M | -$9.0M | $3.0M | -$1.1M | -$6.7M |
| Change in inventory | $11.5M | $9.9M | $4.9M | $8.5M | $4.8M |
| Change in accounts payable | $2.4M | -$13.0M | $1.6M | -$2.8M | $1.3M |
| Purchases of investments | $6.9M | $0 | $0 | — | — |
| Share repurchases | $0 | $40.5M | $5.4M | $563.0K | $0 |
| Debt repaid | — | — | — | $0 | $501.0K |
| Tax withholding on stock comp | $484.0K | $459.0K | $139.0K | $211.0K | $1.8M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding LAB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-12-02 to 2026-08-20
Recent transactions
- Most recent: Mackay Sean (SVP & Chief Business Officer) — Tax withholding of 25,729 shares on 2026-08-20.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Mackay Sean | SVP & Chief Business Officer | Tax withholding | 2026-08-20 | 25,729 |
| Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 2026-08-20 | 28,195 |
| Egholm Michael | President & CEO | Tax withholding | 2026-08-20 | 97,627 |
| Carey Thomas D. | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| Witney Frank | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| Casdin Eli | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| Cox Troy | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| ELOI FENEL M | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| HIBBS KATHY L | Reporting person | Grant / award | 2026-06-18 | 99,116 |
| Casdin Partners Master Fund, L.P. | Director | Open market purchase | 2025-12-04 | 150,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-20 | Mackay Sean | SVP & Chief Business Officer | Tax withholding | 25,729 | $0.67 |
| 2026-08-20 | Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 28,195 | $0.67 |
| 2026-08-20 | Egholm Michael | President & CEO | Tax withholding | 97,627 | $0.67 |
| 2026-08-03 | Egholm Michael | President & CEO | Tax withholding | 362,625 | $0.87 |
| 2026-07-23 | Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 202,476 | $0.90 |
| 2026-06-20 | Mackay Sean | SVP & Chief Business Officer | Grant / award | 500,000 | $0.00 |
| 2026-06-18 | Carey Thomas D. | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-06-18 | Witney Frank | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-06-18 | Casdin Eli | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-06-18 | Cox Troy | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-06-18 | ELOI FENEL M | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-06-18 | HIBBS KATHY L | Reporting person | Grant / award | 99,116 | $0.00 |
| 2026-05-20 | Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 18,871 | $1.00 |
| 2026-05-20 | Mackay Sean | SVP & Chief Business Officer | Tax withholding | 25,729 | $1.00 |
| 2026-05-20 | Egholm Michael | President & CEO | Tax withholding | 97,626 | $1.00 |
| 2026-04-06 | Egholm Michael | President & CEO | Option exercise | 196,513 | $0.00 |
| 2026-04-06 | Egholm Michael | President & CEO | Tax withholding | 95,014 | $0.91 |
| 2026-04-06 | Kim Hanjoon Alex | Chief Financial Officer | Option exercise | 70,183 | $0.00 |
| 2026-04-06 | Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 21,301 | $0.91 |
| 2026-03-20 | Egholm Michael | President & CEO | Grant / award | 1,042,373 | $0.00 |
| 2026-03-20 | Mackay Sean | SVP & Chief Business Officer | Grant / award | 272,107 | $0.00 |
| 2026-03-20 | Kim Hanjoon Alex | Chief Financial Officer | Grant / award | 323,173 | $0.00 |
| 2026-02-26 | Casdin Eli | Reporting person | Grant / award | 52,991 | $1.17 |
| 2026-02-26 | Cox Troy | Reporting person | Grant / award | 57,264 | $1.17 |
| 2026-02-26 | Carey Thomas D. | Reporting person | Grant / award | 51,282 | $1.17 |
| 2026-02-23 | Egholm Michael | President & CEO | Tax withholding | 66,127 | $1.15 |
| 2026-02-23 | Mackay Sean | SVP & Chief Business Officer | Tax withholding | 19,661 | $1.15 |
| 2026-02-23 | Kim Hanjoon Alex | Chief Financial Officer | Tax withholding | 12,740 | $1.15 |
| 2025-12-04 | Casdin Partners Master Fund, L.P. | Director | Open market purchase | 150,000 | $1.45 |
| 2025-12-03 | Casdin Partners Master Fund, L.P. | Director | Open market purchase | 75,000 | $1.44 |
| 2025-12-02 | Casdin Partners Master Fund, L.P. | Director | Open market purchase | 125,000 | $1.42 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:51 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 8-K | 2026-10-05 | View on SEC.gov → |
| 2026-09-30 | 8-K | 2026-09-30 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-08-03 | View on SEC.gov → |
| 2026-07-28 | 8-K | 2026-07-24 | View on SEC.gov → |
| 2026-07-27 | 4 | 2026-07-23 | View on SEC.gov → |
| 2026-07-24 | 8-K | 2026-07-22 | View on SEC.gov → |
| 2026-06-23 | 4 | 2026-06-18 | View on SEC.gov → |
Recent news
Headlines about LAB (Standard BioTools Inc.). Links open the publisher — we don’t host full articles.
-
Rocket Lab (NASDAQ:RKLB) Shares Climb 5.5% - What's Next?
MarketBeat · 2026-10-21 -
Why Is Rocket Lab Stock Surging on Wednesday?
Benzinga · 2026-10-21 -
Rocket Lab Just Had the Worst Week in Its History. Here's What I'd Do With the Stock Now.
Yahoo Finance · 2026-10-21 -
A live webcast on Zai Lab's third-quarter update is set for 8 a.m. ET Nov. 5
Stock Titan · 2026-10-21 -
Rocket Lab Just Had Another Setback. Here’s Why I’m Finally Buying the Stock Anyway
Yahoo Finance · 2026-10-21 -
Why Is Rocket Lab Stock Rising in Pre-Market Trading?
Yahoo Finance · 2026-10-21 -
Rocket Lab Corporation $RKLB Shares Sold by Prime Capital Investment Advisors LLC
MarketBeat · 2026-10-21 -
Why is Rocket Lab stock rallying today?
Investing.com · 2026-10-21
No headlines in this category right now — try “All”.